Advertisement
Screener

EXACT SCIENCES CORP Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)

EXACT SCIENCES CORP Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)

EXACT SCIENCES CORP reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $20.21 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2022-02-22

  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2021-12-31 was $0.00.
  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2021-09-30 was $20.21M, a 90.36% decline year-over-year.
  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2020-12-31 was $0.00.
  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2020-09-30 was $209.67M.
  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2021 was $20.21M, a 90.36% decline from fiscal 2020.
  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2020 was $209.67M.
  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2019 was $0.00.
  • EXACT SCIENCES CORP impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2018 was $0.00.
Period endImpairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 monthImpairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 monthImpairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 monthImpairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
$20.21M
derived: sum of 2 quarters · filed 2022-02-22
$20.21M
10-K · filed 2022-02-22
2021-09-30$20.21M
10-Q · filed 2021-11-02
$20.21M
10-Q · filed 2021-11-02
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
$209.67M
derived: sum of 2 quarters · filed 2022-02-22
$209.67M
10-K · filed 2022-02-22
2020-09-30$209.67M
10-Q · filed 2021-11-02
$209.67M
10-Q · filed 2021-11-02
2019-12-31$0.00
10-K · filed 2022-02-22
2018-12-31$0.00
10-K · filed 2021-02-16